$RXSF ***Solid Due Diligence*** OUTPERFORM Rati
Post# of 225
Posted On: 01/01/2016 11:49:46 AM
$RXSF ***Solid Due Diligence***
OUTPERFORM Rating with $17.41 Target by End of 2016
Expected Revenues by End of 2018 Approx. $150,000,000+ from a $85 BILLION COMBINED MARKET, that's 0.18% which 1-2% is easily attainable. $850m to $1.7B Annually.
Share Structure
500m A/S, 1.378m O/S & 250k Float
Up List to National Exchange .
Insiders Acquired 81% of Outstanding Shares PRIOR to split and PURCHASED $9000 in Commons Immediately after Split. Form 4's Issued.
FDA/510K for SafeDose & MyDose both Multi Billion $ Markets with World Wide Exclusivity and market Cornered with addition of new patents.
Major Pharmaceutical Partner coming due to FDA Prerequisite.
FUTURE CUSTOMERS: HOSPIRA $4.5B Annually (Owned by Pfzier), BAXTER INTERNATIONAL $15B Annually, CAREFUSION owned by Becton- Dickinson $10.2B Annually, SMITH MEDICAL$1B Annually.
In Store Sales at 7,800 CVS Health Stores, 4 National Televised Commercials with CVS.
Current Partners CVS Health, Cardinal Health, McKesson and soon Amerisource, all 4 on NYSE generating Billions.
Expect Government Announcements soon. Drug Prevention is at a peak.
2 Major Products
Rx SafeDose & Rx MyDose
Plus numerous other to be Launched RX DrugSafe, RX DrugSafe Pro, RX DruSafe Mini, RX DrugSafe IC, Rx DrugSafe EMS , Rx DrugSafe MMS, RX DrufSafe Cool & Rx FieldLock, once again Multi Billion $ markets.
Expect MAJOR BANK FINANCING $10's of Millions...hearing $25-$35 Million. Yah thank me later.
$25 PPS is $34m Cap, Company expects $50m Cap relatively easy with sales announcements coming soon. (2016 will be a Big Year)
http://www.rxdrugsafe.com/
OUTPERFORM Rating with $17.41 Target by End of 2016
Expected Revenues by End of 2018 Approx. $150,000,000+ from a $85 BILLION COMBINED MARKET, that's 0.18% which 1-2% is easily attainable. $850m to $1.7B Annually.
Share Structure
500m A/S, 1.378m O/S & 250k Float
Up List to National Exchange .
Insiders Acquired 81% of Outstanding Shares PRIOR to split and PURCHASED $9000 in Commons Immediately after Split. Form 4's Issued.
FDA/510K for SafeDose & MyDose both Multi Billion $ Markets with World Wide Exclusivity and market Cornered with addition of new patents.
Major Pharmaceutical Partner coming due to FDA Prerequisite.
FUTURE CUSTOMERS: HOSPIRA $4.5B Annually (Owned by Pfzier), BAXTER INTERNATIONAL $15B Annually, CAREFUSION owned by Becton- Dickinson $10.2B Annually, SMITH MEDICAL$1B Annually.
In Store Sales at 7,800 CVS Health Stores, 4 National Televised Commercials with CVS.
Current Partners CVS Health, Cardinal Health, McKesson and soon Amerisource, all 4 on NYSE generating Billions.
Expect Government Announcements soon. Drug Prevention is at a peak.
2 Major Products
Rx SafeDose & Rx MyDose
Plus numerous other to be Launched RX DrugSafe, RX DrugSafe Pro, RX DruSafe Mini, RX DrugSafe IC, Rx DrugSafe EMS , Rx DrugSafe MMS, RX DrufSafe Cool & Rx FieldLock, once again Multi Billion $ markets.
Expect MAJOR BANK FINANCING $10's of Millions...hearing $25-$35 Million. Yah thank me later.
$25 PPS is $34m Cap, Company expects $50m Cap relatively easy with sales announcements coming soon. (2016 will be a Big Year)
http://www.rxdrugsafe.com/
(0)
(0)GeneSYS ID, Inc. (GNID) Stock Research Links
Scroll down for more posts ▼